CARsgen Therapeutics Reports Director Resignation and Audit Committee Shortfall Under HKEX Rule 3.21

Bulletin Express

昨天

CARsgen Therapeutics Holdings Limited announced that Non-Executive Director Mr. Huaqing Guo resigned with effect from 30 September 2026 to focus on other business commitments. His departure also ends his role as a member of the company’s Audit Committee.

Mr. Guo confirmed he has no outstanding claims against the company and no disagreements with the Board. The Board expressed gratitude for his tenure and contributions.

Following the resignation, the Audit Committee now consists of two independent non-executive directors—Ms. Xiangke Zhao (chairperson) and Dr. Wen Zhou—leaving the committee below the minimum three-member requirement stipulated by Hong Kong Listing Rule 3.21. The Board aims to appoint a suitable replacement within three months to restore compliance.

As of the announcement date, CARsgen’s Board comprises three executive directors (Dr. Zonghai Li, Dr. Huamao Wang and Dr. Hua Jiang), one remaining non-executive director (Mr. Ronggang Xie) and three independent non-executive directors (Dr. Guangmei Yan, Ms. Xiangke Zhao and Dr. Wen Zhou).

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1137766883"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1137766883\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1137766883?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-30 21:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137766883","market":"hk","top_or_hot":-1,"title":"CARsgen Therapeutics Reports Director Resignation and Audit Committee Shortfall Under HKEX Rule 3.21","media":"Bulletin Express","content":"<p>CARsgen Therapeutics Holdings Limited announced that Non-Executive Director Mr. Huaqing Guo resigned with effect from 30 September 2026 to focus on other business commitments. His departure also ends his role as a member of the company’s Audit Committee.</p>\n<p>Mr. Guo confirmed he has no outstanding claims against the company and no disagreements with the Board. The Board expressed gratitude for his tenure and contributions.</p>\n<p>Following the resignation, the Audit Committee now consists of two independent non-executive directors—Ms. Xiangke Zhao (chairperson) and Dr. Wen Zhou—leaving the committee below the minimum three-member requirement stipulated by Hong Kong Listing Rule 3.21. The Board aims to appoint a suitable replacement within three months to restore compliance.</p>\n<p>As of the announcement date, CARsgen’s Board comprises three executive directors (Dr. Zonghai Li, Dr. Huamao Wang and Dr. Hua Jiang), one remaining non-executive director (Mr. Ronggang Xie) and three independent non-executive directors (Dr. Guangmei Yan, Ms. Xiangke Zhao and Dr. Wen Zhou).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CARsgen Therapeutics Reports Director Resignation and Audit Committee Shortfall Under HKEX Rule 3.21</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCARsgen Therapeutics Reports Director Resignation and Audit Committee Shortfall Under HKEX Rule 3.21\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-30 21:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CARsgen Therapeutics Holdings Limited announced that Non-Executive Director Mr. Huaqing Guo resigned with effect from 30 September 2026 to focus on other business commitments. His departure also ends his role as a member of the company’s Audit Committee.</p>\n<p>Mr. Guo confirmed he has no outstanding claims against the company and no disagreements with the Board. The Board expressed gratitude for his tenure and contributions.</p>\n<p>Following the resignation, the Audit Committee now consists of two independent non-executive directors—Ms. Xiangke Zhao (chairperson) and Dr. Wen Zhou—leaving the committee below the minimum three-member requirement stipulated by Hong Kong Listing Rule 3.21. The Board aims to appoint a suitable replacement within three months to restore compliance.</p>\n<p>As of the announcement date, CARsgen’s Board comprises three executive directors (Dr. Zonghai Li, Dr. Huamao Wang and Dr. Hua Jiang), one remaining non-executive director (Mr. Ronggang Xie) and three independent non-executive directors (Dr. Guangmei Yan, Ms. Xiangke Zhao and Dr. Wen Zhou).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02171","symbol_name":"科济药业-B","start_time":0,"source_url":"","article_id":"1137766883","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137766883","pubTimestamp":1790775766,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CARsgen Therapeutics Holdings Limited announced that Non-Executive Director Mr. Huaqing Guo resigned with effect from 30 September 2026 to focus on other business commitments. His departure also ends...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02171":"科济药业-B"},"translate_title":"CARsgen Therapeutics 根据港交所规则 3.21 报告董事辞职和审计委员会人手不足","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02171":1},"content_text":"CARsgen Therapeutics Holdings Limited announced that Non-Executive Director Mr. Huaqing Guo resigned with effect from 30 September 2026 to focus on other business commitments. His departure also ends his role as a member of the company’s Audit Committee.\nMr. Guo confirmed he has no outstanding claims against the company and no disagreements with the Board. The Board expressed gratitude for his tenure and contributions.\nFollowing the resignation, the Audit Committee now consists of two independent non-executive directors—Ms. Xiangke Zhao (chairperson) and Dr. Wen Zhou—leaving the committee below the minimum three-member requirement stipulated by Hong Kong Listing Rule 3.21. The Board aims to appoint a suitable replacement within three months to restore compliance.\nAs of the announcement date, CARsgen’s Board comprises three executive directors (Dr. Zonghai Li, Dr. Huamao Wang and Dr. Hua Jiang), one remaining non-executive director (Mr. Ronggang Xie) and three independent non-executive directors (Dr. Guangmei Yan, Ms. Xiangke Zhao and Dr. Wen Zhou).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}